Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial.

Hellstrom WJ, Gittelman M, Karlin G, Segerson T, Thibonnier M, Taylor T, Padma-Nathan H.

J Androl. 2002 Nov-Dec;23(6):763-71. No abstract available.

2.

Vardenafil (Levitra) for erectile dysfunction: a systematic review and meta-analysis of clinical trial reports.

Markou S, Perimenis P, Gyftopoulos K, Athanasopoulos A, Barbalias G.

Int J Impot Res. 2004 Dec;16(6):470-8. Review.

PMID:
15229625
3.

[Safety and tolerability of Vardenafil].

Hong K, Jiang H.

Zhonghua Nan Ke Xue. 2006 Sep;12(9):857-60. Review. Chinese.

PMID:
17009542
4.

[Vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy].

Huang YR.

Zhonghua Nan Ke Xue. 2005 Jan;11(1):76-9. Review. Chinese.

PMID:
15704689
5.

Vardenafil: efficacy, tolerability and future directions.

Rice KR, Dean RC.

Expert Opin Drug Metab Toxicol. 2009 May;5(5):553-62. doi: 10.1517/17425250902884108 . Review.

PMID:
19416089
6.

Pharmacology of phosphodiesterase 5 inhibitors.

Carrier S.

Can J Urol. 2003 Feb;10 Suppl 1:12-6. Review.

PMID:
12625845
7.

Vardenafil: a new oral treatment for erectile dysfunction.

Eardley I.

Int J Clin Pract. 2004 Aug;58(8):801-6. Review.

PMID:
15372854
8.

Correlations between increased erection hardness and improvements in emotional well-being and satisfaction outcomes in men treated with sildenafil citrate for erectile dysfunction.

King R, Juenemann KP, Levinson IP, Stecher VJ, Creanga DL.

Int J Impot Res. 2007 Jul-Aug;19(4):398-406. Epub 2007 Mar 15. Review.

PMID:
17361232
9.

Vardenafil: a novel type 5 phosphodiesterase inhibitor for the treatment of erectile dysfunction.

Kendirci M, Bivalacqua TJ, Hellstrom WJ.

Expert Opin Pharmacother. 2004 Apr;5(4):923-32. Review.

PMID:
15102574
11.

A state of art review on vardenafil in men with erectile dysfunction and associated underlying diseases.

Chung E, Broc GB.

Expert Opin Pharmacother. 2011 Jun;12(8):1341-1348. doi: 10.1517/14656566.2011.584064. Review. No abstract available.

PMID:
21548725
12.

Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor.

Sommer F.

Expert Opin Drug Metab Toxicol. 2005 Aug;1(2):295-301. Review.

PMID:
16922644
13.

Vardenafil: update on clinical experience.

Pryor J.

Int J Impot Res. 2002 Feb;14 Suppl 1:S65-9. Review.

14.

Sildenafil citrate (VIAGRA): overall safety profile in 18 double-blind, placebo controlled, clinical trials.

Osterloh IH, Collins M, Wicker P, Wagner G.

Int J Clin Pract Suppl. 1999 Jun;102:3-5. Review. No abstract available.

PMID:
10665110
15.

Erectile dysfunction: management update.

Fazio L, Brock G.

CMAJ. 2004 Apr 27;170(9):1429-37. Review.

16.

Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence.

Morales AM, Mirone V, Dean J, Costa P.

Clin Interv Aging. 2009;4:463-72. Epub 2009 Dec 29. Review.

17.

[New medications for treatment of erectile dysfunction].

Nagai A, Kumon H.

Nihon Rinsho. 2002 Jun;60 Suppl 6:461-4. Review. Japanese. No abstract available.

PMID:
12166201
18.

Sex, the heart, and sildenafil.

Alloggiamento T, Zipp C, Raxwal VK, Ashley E, Dey S, Levine S, Froelicher VF.

Curr Probl Cardiol. 2001 Jun;26(6):388-415. Review. No abstract available.

PMID:
11391247
19.

Erectile dysfunction.

Lue TF.

N Engl J Med. 2000 Jun 15;342(24):1802-13. Review. No abstract available.

PMID:
10853004
20.

Supplemental Content

Support Center